insights_auto
Why is ORX down 3,08%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,85 SEK
arrow_downward
-3,08%(-0,027) 1D
16 ნოე, 17:29:42 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
297,56 მლნ.
Avg. vol.
777,72 ათ.
Volume
415,89 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
297,56 მლნ.
Avg. vol.
777,72 ათ.
Volume
415,89 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
Bloomberg.com
·
1 საათის წინ
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
RealMoney Pro
·
1 საათის წინ
AI Stocks Drag the S&P 500 Back Toward the November 5th Lows
Investing.com
·
2 საათის წინ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
Traders Union
·
51 წუთის წინ
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com